YOLFTbeta
Sunflower Pharmaceuticals Group Co Ltd

Sunflower Pharmaceuticals Group Co Ltd

002737 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

11.81CNY-0.09 (-0.76%)

Price History

Full chart

Market Stats

Previous Close11.90
Open11.82
Day Range11.67 – 11.95
52-Week Range10.88 – 15.43
Volume5.41M
Market Cap6.66B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.44
Dividend Yield1.75%
Beta0.24
50-Day Avg12.59
200-Day Avg13.16

About

Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children's medicines for various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold ailments, rheumatism and bone disease, cardiovascular and cerebrovascular diseases, and general health. The company is also involved in leasing and business services; scientific research and technical services; and wholesale and retail trade. It sells its products under the Sunflower and Little Sunflower brand names. The company was founded in 2005 and is headquartered in Harbin, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jianzhong Zhou
  • Employees5.03K
  • HeadquartersNo. 18, Donghu Road, Harbin, China, 150078, China
  • Websitehttps://www.kuihuayaoye.com

Leadership

  • Mr. Jianzhong ZhouGM & Non-Independent Director · b. 1968
  • Ms. Chunhong WuFinancial Manager · b. 1977
  • Mr. Yang YangDeputy GM & Non-Independent Director · b. 1970
  • Mr. Guangguang ZhouBoard Secretary · b. 1981
  • Mr. Guang Tao LiuDeputy General Manager · b. 1983
  • Mr. Lin XiaoDeputy General Manager · b. 1975
  • Mr. Peng ZhaoDeputy General Manager · b. 1985
  • Li ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.56B1.77B2.18B2.72B3.03B3.36B3.86B4.47B4.37B3.46B4.46B5.09B5.70B3.38B2.32B
Growth (%)-+13.53%+23.22%+24.66%+11.62%+10.83%+14.61%+16.00%-2.24%-20.81%+28.86%+14.20%+11.89%-40.76%-31.36%
Cost of Revenue556.96M662.32M789.47M1.04B1.35B1.42B1.56B1.84B1.83B1.45B1.82B2.16B2.49B1.90B1.43B
Gross Profit1.00B1.11B1.39B1.68B1.69B1.95B2.29B2.63B2.54B2.01B2.64B2.94B3.21B1.48B884.35M
Gross Margin64.27%62.58%63.80%61.72%55.53%57.92%59.44%58.91%58.13%58.12%59.15%57.67%56.27%43.85%38.15%
Operating Expense781.04M802.53M1.08B1.29B1.34B1.61B1.74B1.92B1.78B1.25B1.75B1.85B1.84B844.68M1.10B
Operating Income221.00M305.10M307.85M383.40M340.51M342.70M555.07M715.75M760.41M766.62M885.20M1.08B1.37B636.24M-212.03M
Operating Margin14.18%17.24%14.12%14.10%11.22%10.19%14.40%16.01%17.40%22.14%19.84%21.30%23.98%18.84%-9.15%
EBITDA391.46M361.02M409.46M487.80M424.70M481.05M648.54M779.91M851.72M811.07M935.80M1.29B1.36B625.66M-94.30M
EBITDA Margin25.11%20.40%18.77%17.94%13.99%14.30%16.82%17.44%19.48%23.43%20.98%25.22%23.83%18.53%-4.07%
Net Income190.86M234.24M262.94M301.13M306.60M303.02M424.00M563.28M565.42M584.45M704.74M867.22M1.12B492.05M-257.83M
Net Income Margin12.24%13.23%12.06%11.08%10.10%9.01%11.00%12.60%12.93%16.88%15.80%17.02%19.63%14.57%-11.12%
R&D10.83M29.04M31.33M39.68M47.98M62.05M110.36M121.91M121.68M119.38M139.28M103.20M128.65M115.44M111.11M
R&D as % of Total Revenue0.69%1.64%1.44%1.46%1.58%1.84%2.86%2.73%2.78%3.45%3.12%2.03%2.26%3.42%4.79%
Interest Expense42.77M42.42M39.21M33.72M18.63M11.99M11.13M7.10M12.41M7.62M10.49M10.13M6.34M4.23M3.69M
Interest Expense % of Total Revenue2.74%2.40%1.80%1.24%0.61%0.36%0.29%0.16%0.28%0.22%0.24%0.20%0.11%0.13%0.16%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.56B1.89B2.10B3.73B3.76B4.22B4.47B5.06B5.31B5.11B5.64B7.03B6.88B5.83B5.33B
Total Liabilities1.01B1.14B1.23B1.45B1.15B1.42B1.31B1.62B1.88B1.72B1.70B2.59B1.88B1.24B1.34B
Total Equity529.20M733.02M828.33M2.22B2.45B2.64B2.99B3.27B3.22B3.18B3.71B4.20B4.76B4.38B3.84B
Cash339.52M492.08M438.72M1.80B969.37M905.58M932.09M1.23B1.47B1.65B1.32B2.40B2.29B1.04B852.82M
Total Debt712.74M715.06M682.42M743.93M203.00M330.00M100.00M196.34M426.34M310.48M244.08M436.08M22.06M4.05M-
Net Debt373.23M222.98M243.70M-1.06B-766.37M-575.58M-832.09M-1.03B-1.04B-1.34B-1.08B-1.96B-2.26B-1.04B-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow257.60M327.31M293.34M403.23M125.84M341.23M558.77M866.21M981.33M1.17B865.23M1.97B923.30M-307.48M574.97M
Investing Cash Flow-198.70M-101.84M-104.77M-144.61M-258.60M-374.32M-153.86M-287.15M-313.69M-203.85M-889.72M-644.43M36.20M2.54M-
Financing Cash Flow44.40M-95.51M-235.47M1.09B-721.06M4.44M-395.01M-251.61M-427.82M-783.60M-309.33M-242.01M-1.04B-942.51M-
Capital Expenditure199.10M114.22M194.44M197.71M177.32M159.49M156.88M320.87M374.24M212.73M118.31M152.90M149.16M92.79M96.10M
Free Cash Flow58.51M213.09M98.90M205.51M-51.48M181.74M401.89M545.34M607.09M957.14M746.92M1.82B740.52M-400.27M478.86M
Dividends Paid139.33M90.83M205.94M223.26M71.47M100.58M103.74M299.53M584.00M582.42M201.90M406.73M588.51M885.20M292.12M
FCF to OCF22.71%65.10%33.72%50.97%-40.91%53.26%71.92%62.96%61.86%81.82%86.33%92.24%80.20%130.18%83.29%
Dividend Paid to FCF238.14%42.63%208.23%108.64%-138.84%55.34%25.81%54.92%96.20%60.85%27.03%22.37%79.47%-221.15%61.00%

Earnings

Report DateApr 21, 2015Aug 24, 2015Oct 26, 2015Feb 26, 2016Apr 27, 2016Aug 18, 2016Oct 24, 2016Feb 26, 2017Apr 27, 2017Aug 23, 2017Oct 25, 2017Feb 22, 2018Apr 23, 2018Aug 15, 2018Oct 18, 2018Feb 15, 2019Apr 22, 2019Aug 20, 2019Oct 29, 2019Apr 27, 2020Aug 25, 2020Oct 29, 2020Apr 20, 2021Aug 26, 2021Oct 27, 2021Apr 27, 2022Aug 9, 2022Oct 26, 2022Apr 27, 2023Aug 24, 2023Oct 25, 2023Apr 25, 2024Aug 28, 2024Oct 28, 2024Apr 24, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------
EPS Actual0.140.170.030.180.170.12-0.070.310.170.160.090.300.250.230.110.370.280.240.120.260.140.140.460.140.160.520.310.190.600.390.360.440.400.170.100.04-0.20-0.380.19-0.05
Surprise----------------------------------------
TimingAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap6.66B
Enterprise Value4.16B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.66
Price / Book1.70
EPS-0.44
Book Value6.71
Revenue (TTM)2.51B
Gross Profit (TTM)1.15B
EBITDA-132.49M
Profit Margin-10.36%
Operating Margin-7.98%
Return on Equity-6.70%
Return on Assets-3.26%
Shares Outstanding584.00M
Shares Float250.93M
Beta0.24
Dividend Yield1.75%
Dividend Rate0.20
Payout Ratio0.00%

Dividends

20261×
0.20Jul 17, 2026
20251×
0.50Jul 18, 2025
20241×
1.50Jun 14, 2024
20231×
1.00Jun 7, 2023
20221×
0.70Jun 2, 2022
20211×
0.35Jul 12, 2021
20201×
1.00May 28, 2020
20191×
1.00Apr 23, 2019
20181×
0.50Apr 18, 2018
20171×
0.15Jun 1, 2017
20161×
0.15Aug 2, 2016
20151×
0.09Jun 11, 2015

Stock Splits

  • Apr 18, 20182:1
  • Jun 11, 201520:10